HIMS Loses WeGovy Deal, NURS Gains by 9.49% to $1.73 Per Share

Hims & Hers Health (HIMS) has lost their Novo deal for WeGovy.

Suddenly, millions of HIMS customers need a new telehealth provider for their GLP-1 weight loss drugs.

NIA's Hydreight (TSXV: NURS) is about to capture significant new market share!

NURS gained by 9.49% today to $1.73 per share and has so far gained by 47.86% since NIA's suggestion at $1.17 per share.

NURS is profitable with rapid revenue growth! Click here to read NIA's NURS report!

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA has received compensation from NURS of US$30,000 cash for a three-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.